FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20200402E00088
1. Date of relevant event: 31/03/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02616
4. Name of listed corporation: CStone Pharmaceuticals - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,028,817,603
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Jiang
(Other names) Frank Ningjun
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1213The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2101Beneficial owner
 
 
5,060,052         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position105,490,76210.25
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position100,430,7109.76
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position93,670,710
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position6,760,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
01/07/201701/07/2030HKD1.00USD0.025  2,883,336
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
01/07/201701/07/2030HKD1.00USD0.050  5,750,000
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
01/07/201701/07/2030HKD1.00    2,473,920
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
16/01/202016/01/2033HKD1.00    20,841,912
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202015/07/2030HKD1.00HKD10.690  9,108,094
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202115/07/2031HKD1.00HKD10.690  9,108,095
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202215/07/2032HKD1.00HKD10.690  9,108,095
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202315/07/2033HKD1.00HKD10.690  9,108,095
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202015/07/2030HKD1.00    2,277,023
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202115/07/2031HKD1.00    2,277,024
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202215/07/2032HKD1.00    2,277,024
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
15/07/202315/07/2033HKD1.00    2,277,024
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseYanni Xiao
Long position6,760,000
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
JIANG IRREVOCABLE GIFTING TRUST FBO: YANNI XIAO, Dated November 21, 2018,Addresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position6,760,000
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: 4,048,042 options and 1,012,010 RSUs granted under the Post-IPO ESOP and RSU Scheme, respectively, have lapsed. Box 28 discloses the number of shares to be subscribed upon vesting and exercise of outstanding options and outstanding RSUs granted under various share award schemes of the Company (subject to vesting conditions and adjustments) of which 14,489,904 share awards are vested and transferred to Frank Ningjun Jiang as shares.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 02/04/2020
(dd/mm/yyyy)